Polypipe Group /£GEN
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Polypipe Group
Polypipe Group, trading under the ticker GEN, is a manufacturer specializing in water management and plastic piping systems. Established in 1980, the company operates primarily within the construction and infrastructure sectors. Polypipe offers a wide range of products aimed at addressing critical challenges in water, climate, and ventilation management, contributing to the development of green building solutions.
Ticker
£GEN
Sector
Primary listing
LSE
Employees
3,200
Headquarters
Website
Polypipe Group Metrics
BasicAdvanced
£844M
17.54
£0.19
1.40
£0.13
3.68%
Price and volume
Market cap
£844M
Beta
1.4
52-week high
£5.05
52-week low
£3.01
Average daily volume
685K
Dividend rate
£0.13
Financial strength
Current ratio
1.627
Quick ratio
1.093
Long term debt to equity
25.702
Total debt to equity
26.935
Dividend payout ratio (TTM)
63.27%
Interest coverage (TTM)
7.18%
Profitability
EBITDA (TTM)
114.4
Gross margin (TTM)
44.06%
Net profit margin (TTM)
8.35%
Operating margin (TTM)
13.35%
Effective tax rate (TTM)
21.85%
Revenue per employee (TTM)
£180,000
Management effectiveness
Return on assets (TTM)
4.96%
Return on equity (TTM)
7.68%
Valuation
Price to earnings (TTM)
17.54
Price to revenue (TTM)
1.44
Price to book
1.3
Price to tangible book (TTM)
10.68
Price to free cash flow (TTM)
13.653
Free cash flow yield (TTM)
7.32%
Free cash flow per share (TTM)
0.249
Dividend yield (TTM)
3.68%
Growth
Revenue change (TTM)
5.88%
Earnings per share change (TTM)
105.13%
3-year revenue growth (CAGR)
-1.65%
10-year revenue growth (CAGR)
5.95%
3-year earnings per share growth (CAGR)
1.22%
10-year earnings per share growth (CAGR)
0.85%
3-year dividend per share growth (CAGR)
0.81%
10-year dividend per share growth (CAGR)
9.05%
What the Analysts think about Polypipe Group
Analyst ratings (Buy, Hold, Sell) for Polypipe Group stock.
Bulls say / Bears say
RBC Capital Markets upgraded Genuit to “Outperform” from “Sector Perform”, citing the stock’s undervaluation at 11x 2025 EV/adjusted EBIT compared to peers and potential growth from regulatory catalysts such as AMP8 and the Future Homes Standard
Group revenue for H1 2025 rose 9.3% to £297.8 million (6.1% like-for-like), showing a return to top-line growth in a flat market through focused price and volume strategies
Leverage improved to 1.0x pro-forma EBITDA as of June 30, 2025 (from 1.1x), strengthening the balance sheet and giving the company more flexibility for disciplined bolt-on acquisitions
Underlying operating margin dropped by 100 basis points to 15.0% in H1 2025 due to increased National Insurance and minimum wage expenses impacting profitability
Underlying operating cash conversion fell to 65.1% from 99.5% a year earlier, indicating working capital pressures from higher inventory provisions and timing effects
Genuit’s shares declined over 7% following the H1 2025 results, as investors worried about persistent cost pressures and stagnant market volumes even with top-line growth
Data summarised monthly by Lightyear AI. Last updated on 29 Aug 2025.
Polypipe Group Financial Performance
Revenues and expenses
Polypipe Group Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
Oct1
Polypipe Group
DividendPayment
£0.042Per share
FAQs
What’s the current market cap for Polypipe Group stock?
Polypipe Group (GEN) has a market cap of £844M as of September 18, 2025.
What is the P/E ratio for Polypipe Group stock?
The price to earnings (P/E) ratio for Polypipe Group (GEN) stock is 17.54 as of September 18, 2025.
Does Polypipe Group stock pay dividends?
Yes, the Polypipe Group (GEN) stock pays dividends to shareholders. As of September 18, 2025, the dividend rate is £0.125 and the yield is 3.68%. Polypipe Group has a payout ratio of 63.27% on a trailing twelve-month basis.
When is the next Polypipe Group dividend payment date?
The next Polypipe Group (GEN) dividend payment is scheduled for October 01, 2025.
What is the beta indicator for Polypipe Group ?
Polypipe Group (GEN) has a beta rating of 1.4. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.